I am a breastfeeding mother and i want to know if it is safe to use Maternal Myasthenia Gravis? Is Maternal Myasthenia Gravis safe for nursing mother and child? Does Maternal Myasthenia Gravis extracts into breast milk? Does Maternal Myasthenia Gravis has any long term or short term side effects on infants? Can Maternal Myasthenia Gravis influence milk supply or can Maternal Myasthenia Gravis decrease milk supply in lactating mothers?
- DrLact safety Score for Maternal Myasthenia Gravis is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of Maternal Myasthenia Gravis is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that Maternal Myasthenia Gravis does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of Maternal Myasthenia Gravis safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
There is no further risk of complications with myasthenia during lactation (Klehmet 2010), although the course of puerperium may be unpredictable and may worsen in case of infection or short-term disease (Djelmis 2002). Breastfeeding is feasible and by no means contraindicated. In a series of 33 affected mothers with myasthenia, 76% successfully breastfed (Djelmis 2002); The mother should receive much support along with a effective control of her illness (Giwa-Osagie 1981, Camus 1989). Partial interrupted breastfeeding with formula supplementation may be required in those cases of extreme maternal fatigue (Djelmis 2002).Most treatments for myasthenia gravis (see info on pyridostigmine, neostigmine, prednisone, cyclosporine, azathioprine, immunoglobulin, tacrolimus) are compatible while breastfeeding (Skoglund 1978). Approximately 30% of infants may show a transient neonatal myasthenia due to transplacental passage of acetylcholine anti-receptor antibodies (Skoglund 1978); who should be treated and assisted since hypotonia interferes with a satisfactory feeding. There is a higher risk of transient neonatal myasthenia when the mother has not been thymectomized and with a short-term disease (Djelmis 2002, Roth 2006).There is no conclusive evidence on the excretion in significant amounts of acetylcholine anti-receptor antibodies into breast milk (Djelmis 2002) and/or that it would be responsible for cases of transient neonatal myelitis (Brunner 1992). An association between myasthenia and elevated prolactin levels has been found (Lysenko 1998, Tsinzerling 2006) and anecdotally reported with gigantomastia (Scarabin 2010)
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.